TY - JOUR
T1 - Contemporary critical limb ischemia
T2 - Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care
AU - Kawarada, Osami
AU - Zen, Kan
AU - Hozawa, Koji
AU - Ayabe, Shinobu
AU - Huang, Hsuan Li
AU - Choi, Donghoon
AU - Kim, Su Hong
AU - Kim, Jiyoun
AU - Kato, Taku
AU - Tsubakimoto, Yoshinori
AU - Nakama, Tasuya
AU - Ichihashi, Shigeo
AU - Fujimura, Naoki
AU - Higashimori, Akihiro
AU - Fujihara, Masahiko
AU - Sato, Tomoyasu
AU - Yan, Bryan Ping Yen
AU - Pang, Skyi Yin Chun
AU - Wongwanit, Chumpol
AU - Leong, Yew Pung
AU - Chua, Benjamin
AU - George, Robbie K.
AU - Yokoi, Yoshiaki
AU - Motomura, Hisashi
AU - Obara, Hideaki
N1 - Funding Information:
Acknowledgements This article was supported in part by Endovascu-lar Asia, a nonprofit physician education and research meeting.
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/10/1
Y1 - 2018/10/1
N2 - The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.
AB - The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.
UR - http://www.scopus.com/inward/record.url?scp=85053243471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053243471&partnerID=8YFLogxK
U2 - 10.1007/s12928-018-0523-z
DO - 10.1007/s12928-018-0523-z
M3 - Review article
C2 - 29654408
AN - SCOPUS:85053243471
VL - 33
SP - 297
EP - 312
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
SN - 1868-4300
IS - 4
ER -
